Trial Outcomes & Findings for The Personalised Antibiotic Duration for Cellulitis (PAD-C) Study (NCT NCT05023200)

230 recruited: * 13 excluded * 10 died within 90 days before recurrence * 4 withdrew * 1 loss to follow-up 202 included in final analysis

The Personalised Antibiotic Duration for Cellulitis (PAD-C) Study

Number of Participants with Sustained Recovery

Number of participants with new hospital admission/reattendance containing a cellulitis diagnostic code

Number of participants who recovered within 28 days (investigator assessed)

Number of patients recovered within 28 days (patient-reported)

Number of patients who reported they had returned to work / normal activities within 90 days

The Medical Outcomes Study Short Form 12-Item Health Survey (SF-12) comprises a Physical Component Summary and a Mental Component Summary, each reported as norm-based scores (mean 50, SD 10; range 0-100), where higher values indicate better physical or mental health.

The Medical Outcomes Study Short Form 12-Item Health Survey (SF-12) comprises a Physical Component Summary and a Mental Component Summary, each reported as norm-based scores (mean 50, SD 10; range 0-100), where higher values indicate better physical or mental health.

Repeatability, defined as the consistency of measurements when taken repeatedly at short intervals by the same device under the same conditions, was assessed by calculating the repeatability coefficient. The repeatability coefficient and estimated 95% Confidence Interval were calculated from one temperature measurement and an instant repeated temperature measurement of the limb of interest on each participant on days 0, 1, 2, 3, all combined. The repeatability coefficient can be interpreted as the range (between the negative and positive values of the coefficient) within which the difference between any two repeated measurements on the same subject is expected to lie for 95% of subjects.

Repeatability, defined as the consistency of measurements when taken repeatedly at short intervals by the same device under the same conditions, was assessed by calculating the repeatability coefficient. The repeatability coefficient and estimated 95% Confidence Interval were calculated from one temperature measurement and an instant repeated temperature measurement of the limb of interest on each participant on days 0, 1, 2, 3, all combined. The repeatability coefficient can be interpreted as the range (between the negative and positive values of the coefficient) within which the difference between any two repeated measurements on the same subject is expected to lie for 95% of subjects.

The mean represents the estimated mean difference in affected-limb temperature between measurement methods; the reported 95% interval corresponds to the limits of agreement.